The mortality rate for pregnant people with sickle cell disease is 26 times higher than the national average, research finds.

An organ-on-a-chip device could offer a more personalized treatment for sickle cell disease, which affects 70,000 to 100,000 Americans.

For critically ill children who need blood transfusions, the risk of organ failure or death is the same with fresh or older blood.

Researchers report progress toward using CRISPR-Cas9 to repair the mutation that causes sickle cell disease.